The Programme

September 24-26 2017 — Corinthia Hotel, Prague, Czech Republic

INTRODUCTION

You will have the opportunity to start the conference early on Sunday, September 24 with our educational workshops.

The plenary session on September 25 & 26 will be structured around three main sessions, introduced by our keynote speakers. Additional speakers have been invited based on abstract submissions. The call for abstracts closed on May 15.

The conference will be followed by the EATRIS Combined Platform Meeting for EATRIS members from September 26 afternoon until lunch time on September 27. For more information on that meeting, please visit our dedicated page.

Please note that the programme below is subject to change.

Sunday, 24 September

Pre-conference workshops

13:30 - 19:00
Educational Workshops
Two workshop sessions: 13:30 - 16:00 and 16:30 - 19:00
13:30 - 16:00
Workshop A
TRANSLATING BIOMARKERS INTO IN-VITRO DIAGNOSTICS (IVD)
13:30 - 16:00
Workshop B
CHALLENGES AND BEST PRACTICES IN ACADEMIC DRUG DEVELOPMENT
13:30 - 16:00
Workshop C
DESIGNING YOUR RESEARCH FOR MAXIMUM IMPACT: BUILDING A DATA PACKAGE FIT FOR INVESTMENT
16:00 - 16:30
Coffee break
16:30 - 19:00
Workshop D
POTENCY ASSAYS IN ATMP’S AND VACCINES
16:30 - 19:00
Workshop E
MOLECULAR IMAGING SUPPORTING CNS DRUG DEVELOPMENT
16:30 - 19:00
Workshop F
DESIGNING YOUR RESEARCH FOR MAXIMUM IMPACT – HOW TO ASSESS AND MAXIMISE THE POTENTIAL IMPACT OF YOUR RESEARCH PLAN

Monday, 25 September

08:30 - 09:30
Registration / Posters presentation
09:30 - 09:45
Welcome Words
Representatives of Czech Research Ministry (tbd); Marian Hajduch (IMTM, EATRIS Czech Node); Anton Ussi & Giovanni Migliaccio (EATRIS Executive Board)

Plenary session I: The funder, developer and regulator as partners in innovation

09:45-10:00
Setting the scene, exclusive interview with Dr. Elias Zerhouni (video-recorded)
President, Global R&D, Sanofi
10:00 - 10:20
Personalised medicine activities at EU level
Irene Norstedt, Head of Unit, Innovative and Personalised Medicine, DG Research & Innovation, European Commission
10:20 - 10:40
Presentation title TBA
Isabelle Moulon, Senior Advisor on Stakeholders Engagement, European Medicines Agency
10:40 - 11:00
“The Tale of Two Worlds” – Can Finance rescue lives?
Clayton Heijman, Director, Privium Fund Management
11:00 - 11:20
Academia as enablers of innovation
Anton Ussi & Giovanni Migliaccio, EATRIS Executive Board
11:30 - 12:00
Coffee break / Posters presentation
12:00 - 13:00
Panel session
Increasing efficiency of the system by bringing funder, researcher and regulator closer together
13:00 - 14:00
Lunch / Posters presentation

Plenary session II: Novel approaches in clinical development

14:00-14:05
Setting the scene, exclusive interview with Dr. Elias Zerhouni (video-recorded)
President, Global R&D, Sanofi
14:05 - 14:30
Enabling Innovation through External Networks: Experiences from Clinical Imaging for Pharmaceutical R&D
Philip Murphy, Head Experimental Medicine Imaging, GSK
14:30 - 14:55
From an idea to a medicinal product - A success history
Ragnhild Marie Loeberg, Senior Vice President, Quality & Regulatory Affairs, BAYER Algeta
14:55 - 15:20
Application of PET imaging for clinical development of treatments for neuropsychiatric disorders: Trials and Tribulations
Mark Schmidt, Senior Director R&D, Janssen
15:20 - 15:45
Presentation title TBA
Marian Hajduch, Director, Institute of Molecular and Translational Medicine
15:45 - 16:15
Coffee break / Posters presentation
16:15 - 16:30
miRNAs as accurate and useful biomarkers of Acute Kidney Injury in cardiac surgery patients
María Laura García Bermejo, IRYCIS, Spain
16:30 - 16:45
Metabolomic profiling approach to improve patient’s selection and prediction of outcome for cancer treatment
Susan Costantini, IRCCS- Istituto Nazionale Tumori “Fondazione G. Pascale”, Italy
16:45 - 17:00
A New Path for Accelerating Therapies for Rare Diseases to Patients
James McArthur, President of R&D, Cydan, USA
17:00 - 17:15
18F-FAZA-PET/CT hypoxia imaging in lung cancer and high grade glioma
Maria Picchio, IRCCS-San Raffaele Scientific Institute, Italy
17:15 - 17:30
Immunomonitoring of MSC-treated GVHD patients reveals no obvious markers for therapy response or safety concerns
Johanna Nystedt, Finnish Red Cross Blood Service, Finland
17:30
Closing of the first day
18:00 - 20:00
Networking cocktail for all conference attendees
Bellevue Hall

Tuesday, September 26

Plenary session III: Developing more predictive preclinical tools to better reach proof of concept

09:00 - 09:10
Summary of discussions Day 1 & Setting the scene: exclusive interview with Dr. Elias Zerhouni (video-recorded)
President, Global R&D, Sanofi
09:10 - 09:35
The translational safety challenge from the perspective of Innovative Medicines Initiative (IMI)
Jacques Richard, Scientific Advisor, Sanofi & Scientific Coordinator of the IMI Translational Safety SGG
09:35 - 10:00
Presentation title TBA
Christopher Austin, Director, NIH-NCATS
10:00 - 10:25
Increasing Predictability and Developability of Academic Drug Discovery & Development Projects
Per Arvidsson, Executive Director Drug Discovery & Development, SciLifeLab at Karolinska Institutet
10:30 - 10:45
In vivo imaging and theranostics: a lesson from preclinical studies
Paolo Bigini, Mario Negri Institue for Pharmacological Research, Italy
10:45 - 11:00
Human midbrain-specific organoids as a novel approach for in vitro disease modeling
Kathrin Hemmer, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg
11:00 - 11:30
Coffee break / Posters presentation
11:30 - 11:45
A 3D Microfluidic model for evaluating immune parameters associated to the efficacy of antitumor therapies
Lucia Gabriele, Istituto Superiore di Sanita, Italy
11:45 - 12:00
Novel Enveloping Mechanism of Action in Alzheimer’s Disease
Petr Kocis, Alzheon, USA
12:15 - 12:30
Title TBA
Daisuke Sugiyama, Kyushu University, Japan
12:30 - 12:45
Network-guided modelling allows prediction of sensitivity to all-trans retinoic acid in several tumor types
Maddalena Fratelli, Mario Negri Institute for Pharmacological Research, Italy
12:45 - 13:00
Closing of the conference
13:00 - 14:00
Lunch

Tuesday, September 26

EATRIS Combined Platform Meeting

14:00 - 18:00
EATRIS Combined Platform Meeting (by invitation only – internal meeting)
For more information, please visit: http://eatris.eu/combined-platform-meeting

Wednesday, September 27

09:00 - 14:00
EATRIS Combined Platform Meeting (by invitation only – internal meeting)
For more information, please visit: http://eatris.eu/combined-platform-meeting